Mechanistically, FTO targets the expression of immune checkpoint genes in an m6A-dependent manner via mechanisms such as affecting the stability of LILRB4 mRNA and being recognized by the reader protein YTHDF2, which significantly enhances AML cell sensitivity to T-cell cytotoxicity and thus overcomes immune escape39. Here, LILRB4 is linked to acute myeloid leukemia.